|
|
|
|
|
Cardiovascular Research at Sentara Norfolk General Hospital
Physicians at Sentara Cardiovascular Research Institute Are Leading Efforts to Improve Patient Outcomes
|
|
Since 2005, Sentara Cardiovascular Research Institute physicians have advanced our understanding of cardiovascular disease. Thanks to Sentara discoveries, patients enjoy better outcomes and greater quality of life. Now, Sentara researchers are spearheading efforts to use innovative medical devices and surgical techniques to help patients live healthier, longer lives. Learn more about our ongoing research efforts:
|
|
|
|
|
TAVR for Patients with Low Surgical Risk
|
|
The PARTNER 3 clinical trial looks at TAVR for low surgical risk patients living with severe, calcific aortic stenosis. This includes the use of TAVR before symptoms develop.
|
READ MORE
|
|
|
|
|
Broadening Options for Treatment of Mitral Valve Regurgitation
|
|
Researchers at Sentara Cardiovascular Research Institute are examining new surgical approaches, both transcatheterally and through the sixth intercostal space, for a minimally invasive delivery of three devices — the Intrepid™, Cardioband™ and MitraClip®.
|
|
READ MORE
|
|
|
|
|
Watchman for Closure of Left Atrial Appendage
|
|
Doctors are studying a minimally invasive method of closing the left atrial appendage in some patients with persistent or paroxysmal atrial fibrillation. The clinical trial, called Pinnacle FLX, looks to determine the safety and effectiveness of the updated Watchman device.
|
|
READ MORE
|
|
|
|
|
BROADCASTMED